Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 3

Comparison of AUROC curve values among noninvasive markers for predicting metabolic syndrome.

	AUROC	95% confidence interval	Standard error	P value
All subjects
LAP	0.884	0.893–0.901	0.002	<0.001
FLI	0.875	0.871–0.879	0.002	<0.001
TG	0.853	0.849–0.858	0.002	<0.001
HDL	0.820	0.815–0.825	0.003	<0.001
WC	0.817	0.812–0.821	0.002	<0.001
BMI	0.785	0.779–0.790	0.003	<0.001
Fasting glucose	0.775	0.769–0.781	0.003	<0.001
GGT	0.724	0.717–0.730	0.003	<0.001
Fatty liver	0.704	0.697–0.710	0.003	<0.001
ALT	0.691	0.684–0.698	0.003	<0.001
LDL	0.548	0.541–0.556	0.004	<0.001
Cholesterol	0.543	0.536–0.550	0.004	<0.001
Female subjects
LAP	0.927	0.922–0.933	0.003	<0.001
FLI	0.916	0.910–0.922	0.003	<0.001
TG	0.874	0.866–0.882	0.004	<0.001
WC	0.853	0.845–0.862	0.004	<0.001
Fasting glucose	0.850	0.840–0.860	0.005	<0.001
BMI	0.833	0.824–0.842	0.005	<0.001
HDL	0.825	0.816–0.835	0.005	<0.001
Fatty liver	0.747	0.736–0.759	0.006	<0.001
GGT	0.733	0.721–0.744	0.006	<0.001
ALT	0.693	0.681–0.706	0.006	<0.001
LDL	0.591	0.577–0.604	0.007	<0.001
Cholesterol	0.575	0.562–0.589	0.007	<0.001
Male subjects
LAP	0.856	0.850–0.862	0.003	<0.001
TG	0.825	0.818–0.831	0.003	<0.001
FLI	0.818	0.812–0.825	0.003	<0.001
HDL	0.780	0.773–0.788	0.004	<0.001
Fasting glucose	0.744	0.736–0.752	0.004	<0.001
WC	0.741	0.733–0.748	0.004	<0.001
BMI	0.723	0.716–0.731	0.004	<0.001
GGT	0.659	0.650–0.667	0.004	<0.001
ALT	0.634	0.625–0.643	0.004	<0.001
Fatty liver	0.658	0.650–0.667	0.004	<0.001
Cholesterol	0.542	0.533–0.551	0.005	<0.001
LDL	0.518	0.508–0.527	0.005	<0.001

AUROC, area under the receiver operating characteristic; LAP, lipid accumulation product; FLI, fatty liver index; TG, triglyceride; HDL, high-density lipoprotein; WC, waist circumference; BMI, body mass index; GGT, gamma-glutamyl transferase; ALT: alanine aminotransferase; LDL, low-density lipoprotein.